Transient splenomegaly in acute pancreatitis

Acute pancreatitis is a common condition with variable clinical severity. While many studies have focused on pancreatic imaging, the spleen's role in this disease remains less explored. Prior research has shown that splenic enlargement can occur in various inflammatory and circulatory conditions. However, no prior work had resolved whether splenic volume changes are a consistent feature of acute pancreatitis. This gap motivated the need to investigate serial splenic volume changes in patients with this condition. The current knowledge does not clarify the frequency or duration of such changes. It was already known that abdominal CT is a standard diagnostic tool for acute pancreatitis. But the spleen's response to acute inflammation in the pancreas had not been systematically evaluated. This study aimed to address that uncertainty and provide a clearer understanding of splenic behavior in the context of acute pancreatitis.

The study aimed to evaluate how splenic volume changes over time in patients diagnosed with acute pancreatitis. Specifically, the researchers wanted to determine if splenomegaly is a transient phenomenon in this condition. They also sought to identify any correlations between the magnitude of splenic enlargement and the severity of the disease. The motivation for this study stemmed from the lack of clear data on the spleen's response to acute pancreatitis. By analyzing serial CT scans, the researchers hoped to clarify the temporal pattern of splenic volume changes. They also aimed to explore whether these changes could serve as a marker for disease severity or complications. The study's design allowed for a retrospective analysis of patients who had undergone multiple CT scans. This approach enabled the researchers to track splenic volume changes over two distinct follow-up periods.

The researchers conducted a retrospective analysis of 25 patients with acute pancreatitis who had undergone abdominal CT scans. These patients were selected based on having at least one follow-up CT scan after the initial examination. The first follow-up scan occurred between 4 and 30 days after the initial scan, while the second occurred between 31 and 100 days. Splenic volume was measured in each scan and compared across time points. The percentage change in volume was calculated for both follow-up periods. The study also compared patients with a greater than twofold increase in splenic volume to those with a smaller increase. Clinical data such as disease severity, complications, and hospital stay duration were collected for analysis. The researchers used statistical methods to assess the significance of the observed changes and correlations.

The study found that splenic volume increased significantly in the first follow-up CT scan compared to the initial scan. The mean splenic volume rose from 124.8 cm³ to 197.8 cm³, representing a 65.5% increase on average. This increase was statistically significant (p < 0.0001). However, the volume decreased in the second follow-up scan to 179.7 cm³, which was still higher than the initial measurement (p < 0.002). Five patients experienced a splenic volume increase exceeding 200%, and these individuals had more severe disease. They were more likely to have pseudocysts requiring surgical drainage (p < 0.05) and pleural effusion (p < 0.01). These patients also experienced splenic vein thrombosis or compression (p < 0.05) and had longer hospital stays (p < 0.02). The findings suggest that splenomegaly is a common and transient feature of acute pancreatitis, particularly in more severe cases.

The authors concluded that transient splenomegaly is a common occurrence in acute pancreatitis. This phenomenon was more frequently observed in patients with severe or complicated disease. The study suggests that splenic enlargement may be due to factors such as splenic vein obstruction or stenosis. Non-specified acute splenitis was also considered a possible contributor. The findings do not establish a causal relationship but indicate a strong association between splenic volume changes and disease severity. The researchers propose that these changes may reflect underlying circulatory or inflammatory processes. However, the study does not claim that splenomegaly is an essential diagnostic marker. The authors emphasize the need for further research to clarify the mechanisms behind these observations. The study does not suggest that splenic volume should be used as a primary diagnostic tool for acute pancreatitis.